Vitamin C retards the growth and motility of liver cancer cells huh 7 in wound healing assay
Abdel-Hamid NM, Nazmy MH, Mahmoud AW, Fawzy MA, Youssof M. 2011. A survey on herbal management of hepatocellular carcinoma. World Journal of Hepatology 3, 175-83.
Cameron E, Pauling L. 1976. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. PNAS 73, 3685-9.
Campbell A, Jack T, Cameron E. 1991. Reticulum Cell Sarcoma: Two Complete ‘Spontaneous’ Regressions, in Response to High-Dose Ascorbic Acid Therapy. Oncology 48, 495-7.
Carcamo JM, Pedraza A, Borquez-Ojeda O, Golde DW. 2002. Vitamin C Suppresses TNFα Induced NFκB Activation by Inhibiting Iκβα Phosphorylation. Biochemistry 41, 12995-13002.
Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. 2008. Pharmacologic doses of ascorbate act as a pro oxidant and decrease growth of aggressive tumor xenografts in mice. PNAS 105, 11105-11109.
Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J. 2014. Intravenous vitamin C and cancer: a systematic review. Integrative Cancer Therapies 13, 280-300.
Graumlich JF, Ludden TM, Conry-Cantilena C, Cantilena LR, Wang Y, Levine M. 1997. Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharmaceutical Research 14, 1133-9.
Hoffer LJ, Robitaille L, Zakarian R, Melnychuk D, Kavan P, Agulnik J. 2015. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial. PloS One 10, e0120228.
Jacobs C, Hutton B, Ng T, Shorr R, Clemons M. 2015. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist 20, 210-23.
Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR. 1996. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. PNAS 93, 3704-9.
Liang CC, Park AY, Guan JL. 2007. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols 2, 329-33.
Mc Glynn KA, London WT. 2005. Epidemiology and natural history of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 19, 3-23.
Raza MI, Sikandar A, Sadia A. 2016. Pharmacological Ascorbate triggers apoptotic pathway in Liver cancer cells via up regulation of TNF-α. International Journal of Biosciences 9, 253-258.
Stephenson CM, Levin RD, Spector T, Lis CG. 2013. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemotherapy and Pharmacology 72, 139-46.
Unlu A, Kirca O, Ozdogan M, Nayır E. 2016. High-dose vitamin C and cancer. Journal of Oncological Sciences 1, 10-2.